オステオクラストはNK細胞の抗癌活動に影響する
Clarissa Orrico1,2, Matteo Visca1, Monica Parodi3
1Bone and Dental Bioengineering Lab, Centro Interdipartimentale di Ricerca (CIR) Dental School, Department of Surgical Sciences, University of Turin, Turin, Italy.
Frontiers in immunology
|February 16, 2026
まとめ
オステオクラスト (OCs) は自然殺生 (NK) 細胞の活動を低下させ,骨の非小細胞肺がん幹細胞 (NSCLC CSC) の成長を促します. この研究は,NSCLCの骨転移に対する免疫応答を抑制するOCsの役割を明らかにしています.
科学分野:
- 免疫学 免疫学とは
- 腫瘍学 腫瘍学
- 細胞生物学 細胞生物学
背景:
- 非小細胞肺がん幹細胞 (NSCLC CSCs) は,骨結晶 (OCs) と相互作用し,免疫抑制性骨の微環境を作り出すことで骨転移を誘導する.
- ナチュラルキラー (NK) 細胞は,がん細胞を排除できる重要な免疫細胞です.
研究 の 目的:
- OCs,IL-15刺激されたNK細胞,NSCLC CSCsの相互作用を調査する.
- NK細胞がOCsとNSCLC CSCsのプロメタスタティッククロストックに干渉できるかどうかを判断する.
主な方法:
- A549細胞系から派生したOCs,NK細胞,NSCLC CSCsのインビトロ共同培養は,プラスチックと骨のスライスで確立されました.
- OCの活性は,タルトレート耐性酸ホスファターゼ (TRAP) の定量化と再吸収領域の測定によって評価されました.
- NK細胞のフェノタイプ,受容体/リガンドの発現,およびデグラヌレーション活性 (CD107a) はフローサイトメトリで分析された.
主要な成果:
- NK細胞とNSCLCのCSCと共同培養されたOCは,TRAPの活性と再吸収が低下したことを示した.
- NK細胞は,驚くべきことに,NSCLC CSCの粘着と骨のスライスでの成長を促進しました.
- OCsおよび/またはNSCLC CSCとの共培養は,NK細胞の疲労を引き起こし,抑制受容体 (TIGIT, TIM3) の増加と減少したデグラヌレーションが特徴でした.
結論:
- オステオクラストはNK細胞の細胞毒性活動に悪影響を及ぼし,それによってNSCLCCSCの骨の成長を促進します.
- この研究は,NSCLCの骨転移に寄与するNK細胞機能を抑制することによって,免疫微環境を調節するOCの新たな役割を明らかにしています.
関連する概念動画
Cytotoxic T Cells-mediated Immune Response
7.6K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.6K
Cells of the Innate Immune Response
9.6K
The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
9.6K
Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
Immune Surveillance by NK Cells and Phagocytes
8.9K
Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
8.9K
Cancer Stem Cells and Tumor Maintenance
6.1K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.1K
Inhibition of Cdk Activity
6.0K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.0K


